Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting

Diagn Microbiol Infect Dis. 2011 Aug;70(4):486-91. doi: 10.1016/j.diagmicrobio.2011.04.011.

Abstract

In this study, the utility and impact of hepatitis C virus (HCV) core antigen (Cag) detection via a commercial assay have been evaluated in diagnostic laboratory conditions. In a total of 272 samples from 226 individuals, HCV RNA was detected in 81.3% and anti-HCV antibody prevalence was 86.4%. HCV Cag reactivity was identified in 59.9% of the samples and in 75.8% with detectable RNA. The sensitivity and specificity of HCV Cag assay have been calculated as 75.8% and 95.1%, respectively, and agreement between HCV RNA and HCV Cag was moderate (κ = 0.554). HCV Cag and RNA levels were highly correlated (r = 0.915 and 0.937). A viral load threshold of 10(3) IU/mL has been recognized, above which the correlation with RNA became statistically significant and sensitivity increased to 90.9%. Detection and quantification of HCV core antigen have been observed as a strong alternative to nucleic acid testing for HCV monitorization.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Antigens, Viral / blood*
  • Child
  • Child, Preschool
  • Clinical Laboratory Techniques / methods*
  • Hepatitis C / diagnosis*
  • Hepatitis C Antibodies / blood
  • Humans
  • Infant
  • Infant, Newborn
  • RNA, Viral / blood
  • Sensitivity and Specificity
  • Viral Core Proteins / blood*
  • Viral Load

Substances

  • Antigens, Viral
  • Hepatitis C Antibodies
  • RNA, Viral
  • Viral Core Proteins
  • nucleocapsid protein, Hepatitis C virus